Home > News > Professor explores nanotech for cancer
April 21st, 2008
Professor explores nanotech for cancer
Abstract:
Mansoor Amiji is working on finding a way to deliver drugs to cancer patients using nanomedicine.
Amiji, 44, an associate department chairman in the Pharmaceutical Sciences Department at Northeastern University's School of Pharmacy, is involved with a research group funded by the National Institutes of Health and the National Cancer Institute for the project, which involves the combination of nanotechnology and medicine to treat cancer patients.
Nanomedicine treats diseases, like cancer, at the molecular level, said Amiji. Such technology could be used as a way to target the sick part of a person's body, delivering medicine to the diseased area without harming the rest of the body, he said. In nanomedicine, drugs are delivered to cancer cells through nanoparticles, which are so small that they are able to penetrate through to the protein and DNA inside of the cells of diseased tissues. They are designed to carry anti-cancer drugs and bring that medication all the way to the diseased cells in a person's body without harming the healthy cells.
Source:
indianewengland.com
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||